REG1A and diabetes mellitus: Given the absence of glycosylation sites in Reg proteins, we initially employed a prokaryotic expression system to produce recombinant Reg family proteins (rRegs) and their derived peptides for therapeutic activity evaluation in pancreatitis and diabetes models.